Beta-thalassemia
📧 Sign up to get email alerts when something new happens for Beta-thalassemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
NIAID-sponsored clinical trial update indicates recruitment is ongoing to collect human biospecimens for basic and clinical research into gl…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial of ALS20-101, a lentiviral gene therapy for beta-thalassemia, is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT) [Phase 3]
A Phase 3 pediatric study evaluating mitapivat for transfusion-dependent alpha- and beta-thalassemia to assess efficacy, pharmacokinetics, a…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With α- or β-Non-Transfusion-Dependent Thalassemia [Phase 3]
This clinical trial update describes a Phase 3 study to evaluate the efficacy, pharmacokinetics, and safety of mitapivat in pediatric partic…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT) [Phase 2]
This is a Phase 2 clinical trial evaluating an immune suppression treatment for people with sickle cell disease or beta-thalassemia undergoi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Evaluation of Micro RNA-155 Expression in Relation to Alloantibody Formation in Transfusion-Dependent Patients
This research study from Assiut University investigates how microRNA-155 expression relates to the formation of alloantibodies in transfusio…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease [Phase 3]
Phase 3 clinical trial update for CTX001 (exagamglogene autotemcel) assessing a single dose in transfusion-dependent beta-thalassemia and se…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia [Phase 1, Phase 2]
NHLBI-sponsored clinical trial update describes adding JSP191, a C-kit antibody, to a nonmyeloablative hematopoietic cell transplantation re…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT) [Phase 3]
A Phase 3 clinical trial update reports ongoing evaluation of CTX001 for safety and efficacy in pediatric patients with transfusion-dependen…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia [Phase 2]
This document announces a Phase 2 clinical trial evaluating the safety and efficacy of AND017 in patients with beta-thalassemia, currently r…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: A Follow-up Study to Evaluate the Long-term Safety and Efficacy in Participants Who Received CS-101 Injection
A follow-up clinical trial update evaluating the long-term safety and efficacy of CS-101 injections in participants with Beta-thalassemia, w…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: A Long-term Follow-up Study in Participants Who Received CS-101
This clinical trial update reports a long-term follow-up study of participants who received CS-101 for beta-thalassemia. Enrollment is by in…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies [Phase 1]
Phase 1 clinical trial evaluating hematopoietic stem cell BCL11A enhancer gene editing for severe sickle cell disease and beta-thalassemia, …
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Evaluating the Clinical Efficacy and Safety of Luspatercept Combined With Thalidomide in the Treatment of β-TDT Patients [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of luspatercept in combination with thalidomide for transfusion-dependent beta-t…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia [Phase 1, Phase 2]
BRL-101 is in Phase 1/2 trials for transfusion-dependent beta-thalassemia and is currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia [Phase 2]
This is a Phase 2 pediatric safety and pharmacokinetics study of luspatercept (ACE-536) in children with beta-thalassemia, currently recruit…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Combination of Thalidomide and Hydroxyuria in Transfusion Dependent Thalasemmia [Phase 2]
A Phase 2 clinical trial is investigating the combination of thalidomide and hydroxyurea in patients with transfusion-dependent beta-thalass…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: An Open-label Study of a Gene Therapy Product (Vebeglogene Autotemcel) in Transfusion Dependent Beta-Thalassemia [Phase 1, Phase 2]
An open-label Phase 1/2 trial evaluating Vebeglogene Autotemcel for transfusion-dependent beta-thalassemia. The study is currently recruitin…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials [Phase 3]
This clinical trial update describes a Phase 3 study evaluating the long-term safety of luspatercept in participants who have previously par…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India [Phase 4]
Phase 4 clinical trial evaluating the safety and effectiveness of luspatercept for transfusion-dependent anemia associated with myelodysplas…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Evaluation of Physiological and Psychological Factors Involved in Exercise Intolerance in Patients With β-TTD [NA]
A clinical trial is currently recruiting to evaluate physiological and psychological factors involved in exercise intolerance in patients wi…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes [Phase 2]
A Phase 2 clinical trial update for SP-420 in transfusion-dependent beta-thalassemia and low-risk myelodysplastic syndromes, currently recru…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: YOLT-204 in Patients With Hemoglobinopathies [EARLY_Phase 1]
This is an early Phase 1 clinical trial update for YOLT-204 in patients with hemoglobinopathies, including transfusion-dependent beta-thalas…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: A Long-term Follow-up Study in Participants Who Received CS-101 [NA]
A long-term follow-up study of participants who received CS-101 for beta-thalassemia is ongoing, with the study currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Evaluating the Effect of N-Acetyl Cysteine and Alpha Lipoic Acid in Patients With Beta Thalassemia [Phase 3]
Phase 3 clinical trial evaluating the combination of N-Acetyl Cysteine and Alpha Lipoic Acid in Beta-thalassemia is currently not recruiting…